MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd)
Drug Alert Number: EL(26)A/07
Date issued: 04 February 2026
Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters.
DMRC reference number: DMRC – 38319360
Marketing Authorisation Holder: Aspar Pharmaceuticals Ltd
Medicine Details
- Ibuprofen 200 mg Tablets
- Ibucalm 200 mg Tablets
PL: 08977/0016
Active ingredient: Ibuprofen
SNOMED code: N/A
GTIN: 5010441006481 (Numark), 5060057401989 (Almus), 5024071270358 (Ibucalm)
Affected Lot Batch Numbers:
| Batch No. | Expiry Date | Pack Size | First Distributed |
| 250135 Almus | 31/12/2026 | 24 | 18/06/2025 |
| 250399 Almus | 30/06/2027 | 24 | 04/08/2025 |
| 250125 Numark | 31/12/2026 | 24 | 27/05/2025 |
| 250109 Aspar | 31/12/2026 | 48 | 25/03/2025 |
Background
Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. The investigation confirmed that other batches were not impacted since the issue is related to a specific batch of aluminium foil utilised for these four batches of tablets. These products are Pharmacy (P) medicines and can only be sold or dispensed from a registered pharmacy premises by a pharmacist, or by staff acting under their direct supervision.
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
View full alert here.
Advice for Healthcare Professionals to Provide to Patients
No further action is required by patients as this recall is being undertaken at a Pharmacy and Wholesaler level as a precautionary measure. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.
Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Additional Information
For all enquiries regarding this product, please call 020 8205 9846 extension 2209 or email adrian.zahra@aspar.co.uk.
The post MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) appeared first on Community Pharmacy England.